Fig. 3
From: A comprehensive metabolic profiling of the metabolically healthy obesity phenotype
MUFAs were higher, whereas other fatty acids were lower in MUO subjects. The forest plot displays the β regression coefficients (mean difference) and 95% confidence interval for MUO vs MHO subjects (circles). Estimates on the right and left side of the zero-line translates to higher and lower than MHO subjects, respectively. Color denotes nominal significance level. Abbreviations: 16:1/16:0 ratio, Ratio of palmitoleic acid to palmitic acid; 18:1/18:0 ratio, Ratio of oleic acid to stearic acid; Acetate, Acetate; Butyrate, Butyrate; C14:0, Myristic acid; C15:0, Pentadecylic acid; C16:0, Palmitic acid; C16:1, Palmitoleic acid; C18:0, Stearic acid; C18:1,c11, NA; C18:1,c9, Oleic acid; C18:1,t6–11, Vaccenic acid; C18:2,n-6, Linoleic acid (LA); C18:3,n-6, Gamma-Linolenic acid (GLA); C20:0, Arachidic acid; C20:2,n-6, Dihomolinoleic acid; C20:3,n-6, Dihomo-γ-linolenic acid; C20:4,n-6, Arachidonic acid (AA); C20:5,n-3, Eicosapentaenoic acid (EPA); C22:0, Behenic acid; C22:4,n-6, Adrenic acid (AdA); C22:5,n-3, Docosapentaenoic acid (DPA); C22:5,n-6, Docosapentaenoic acid (Osbond acid); C22:6,n-3, Docosahexaenoic acid (DHA); C23:0, Tricosylic acid; C24:0, Lignoceric acid; C24:1,n-9, Nervonic acid; d5desat, Delta 5-desaturase; d6desat, Delta 6-desaturase; MHO, Metabolically healthy obese subjects; MUFA, Monounsaturated fatty acids; MUO, Metabolically unhealthy obese subjects; n6/n3 ratio, NA; Propionate, Propionate; PUFA, Polyunsaturated fatty acids; SFA, Saturated fatty acids